Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

Study Identifier
192024-049
CT.gov Identifier
NCT01216943
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
    • Study Drug
  • bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Glaucoma and/or ocular hypertension in both eyes * Requires IOP-lowering treatment in both eyes
    Exclusion Criteria:
    * Other active ocular disease other than glaucoma or ocular hypertension (eg, uveitis, ocular infections or severe dry eye) * Current or anticipated use of ocular medications other than study medications, except for intermittent use of artificial tears * Use of oral, injectable or topical corticosteroids within 21 days * Iridectomy or laser peripheral iridotomy in the study eye within 3 months * Uncomplicated cataract surgery in the study eye within 6 months * Incisional glaucoma surgery in the study eye within 12 months

    Protocol Summary

    This study will investigate the safety and efficacy of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) in patients with glaucoma or ocular hypertension who have elevated intraocular pressure (IOP) on brimonidine/timolol ophthalmic solution.

    Study Locations

    Location
    Status
    Location
    Coimbatore, Tamil Nadu, India
    Status
    Not applicable